Enrollment is nearing completion for two Phase 2 clinical trials testing the experimental treatment ELX-02 in people with cystic fibrosis (CF), according to Eloxx Pharmaceuticals, the company developing ELX-02. “We expect full enrollment to be achieved during the first quarter of 2020, and to report topline results during the first half of 2020,” Eloxx stated […]
The post Enrollment Nearly Complete for Phase 2 Clinical Trials Testing ELX-02 in CF Patients appeared first on Cystic Fibrosis News Today. |
No comments:
Post a Comment